Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or Pyelonephritis
Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the microbiological cure rate of doripenem versus a
comparator antibiotic in the treatment of patients with complicated urinary tract infection
or pyelonephritis. The study will also characterize the safety and tolerability of treatment
with doripenem in patients with complicated urinary tract infection or pyelonephritis.
Phase:
Phase 3
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.